Memory EncodingNCT07597603
Unconscious Mind Training
A study testing Intervention H22 in people with Memory Encoding and Memory, run by Dream Video LLC at 1 site in United States.
Trial summary
H22 - Unconscious Mind Training and Memory Encoding Phase 2.1 in progress. The core problem this clinical trial, H22, seeks to address is the pervasive challenge of modifying deeply ingrained, often unconscious, unwanted behaviors within the general population. Read more about this study
- Who is it for?
- Ages 10 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Memory Encoding, Memory, Behavior Change Interventions
- What is being tested?
- Intervention H22
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- Jul 2027to Jan 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 75 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Can read and write
- Willing and able to follow the requirements of the protocol
Who cannot join
- Medical instability, restlessness, or other factors that would compromise data acquisition
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
N/A - Remote Study
Naples, Florida, 34119
Matthew Quitto II, 917 342 2895, dream@dreamholdingsllc.com
About this study
Official title: H22 - Unconscious Mind Training and Memory Encoding
H22 - Unconscious Mind Training and Memory Encoding
Phase 2.1 in progress.
Read more
The core problem this clinical trial, H22, seeks to address is the pervasive challenge of modifying deeply ingrained, often unconscious, unwanted behaviors within the general population. Many individuals struggle with habits or actions that negatively impact quality of life, productivity, or well-being, yet conventional methods often fall short due to the unconscious nature of these behaviors.
Specifically, the trial aims to investigate the efficacy of H22, a novel intervention designed to engage and train the unconscious mind, in mitigating these unwanted behaviors. The central hypothesis guiding this research is that H22 training will empower volunteers to significantly reduce the frequency and intensity of identified unwanted behaviors.
Phase 1 Results:
The trial took place in Shagamu, Nigeria, between July 25, 2026, and August 7, 2026. The study monitored 20 participants over a 14-day intervention period, evaluating their baseline assessment scores, end-of-week progress across Weeks 1 and 2, and their decisions regarding whether to continue integrating Study H22 into daily life.
All 20 enrolled participants completed the full 14 days, yielding a 100% study retention rate. Participant scores improved significantly over the 14 days, increasing from a baseline average of 14.37 to 63.00 at Week 1, and reaching 99.40 by Week 2. At the conclusion of the trial, 85% of participants (17 of 20) chose to continue Study H22 in daily life.
Read the detailed description
This investigation will rigorously evaluate: Does H22 demonstrably lower the number of unwanted behaviors reported by participants over the trial period, indicating a tangible and measurable impact?
Timeline for Observable Results: What is the typical duration required to observe statistically significant results and behavioral changes when utilizing the H22 methodology, providing insights into its practical application and patient expectations?
To achieve these objectives, participants will engage in a structured and consistent protocol:
Daily H22 Engagement. Each volunteer will commit to performing the H22 training exercises daily for a continuous period of two weeks. This consistent engagement is crucial for assessing the cumulative impact of the intervention on unconscious conditioning.
Mid-Trial Unconscious Mind Survey: After the first week of the trial, participants will complete a specialized survey. This survey is designed to gather qualitative and quantitative data regarding perception of changes in participants unconscious thought patterns, behavioral triggers, and overall mental state as a result of H22.
Behavioral Monitoring Diary. Participants will maintain a daily diary to meticulously record the number of instances participants successfully remembered not to engage in their specified unwanted behavior. This self-reporting mechanism will provide critical empirical data to track progress and validate the effectiveness of H22 in promoting conscious control over previously unconscious actions.
Through this comprehensive approach, this study endeavors to determine if H22 offers a viable, innovative solution for behavioral modification by targeting the unconscious mind, thereby addressing a significant unmet need in personal development and therapeutic interventions.
The design of the intervention is centered around simplicity and consistency: a once-a-day engagement. This frequency is strategically chosen to:
Minimize Barriers to Entry: A short, daily commitment is less daunting than lengthy, infrequent sessions, increasing user adherence.
Promote Habit Formation: Regular, brief interaction facilitates the establishment of a sustainable routine, crucial for long-term results.
Optimize Efficacy: Consistent, focused engagement. The interventions provided by the Investigator are primarily behavioral. Investigators recognize that sustained improvement with the unconscious mind is more than just instruction; it demands a change in daily habits and a commitment to ongoing self-care.
- Conditions
- Memory Encoding, Memory, Behavior Change Interventions, Habits
- Being tested
- Intervention H22
- Keywords
- Behavior, Cognitive ability, Unconscious mind
- Medical subject headings
- Habits, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intervention H22Behavioural
Unconscious Mind Training.
| Study group | Role | What they receive |
|---|---|---|
| H22 #1 | Experimental | H22 interventions are administered once daily over a period of fourteen days. Receives: Behavioral: Intervention H22 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of volunteers achieving measurable improvements with unconscious training following a two-week treatment protocol.
Measured: From enrollment to the end of treatment at 2 weeks
Compare the number of participants experiencing treatment-related adverse events versus those with positive treatment outcomes.
Measured: From enrollment to the end of treatment at 2 weeks.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2026
- Study startJul 2027 (estimated)
- Primary completionJan 2028 (estimated)
- Study completionJan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Memory EncodingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Dream Video LLC
- Sponsor type
- University, hospital or other
- Collaborators
- Dream Holdings Research
- Responsible party
- Sponsor
- Investigators
- Matthew Quitto II, Study director, Dream Video LLC
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07597603
- Sponsor's protocol ID
- H22
- Status last verified
- Oct 2026
- First submitted
- 13 May 2026
- Last updated
- 7 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Meng F, Li A, You Y, Xie C. Motor expertise modulates unconscious rather than conscious executive control. PeerJ. 2019 Feb 5;7:e6387. doi: 10.7717/peerj.6387. eCollection 2019.
PubMed 30740277Desender K, Van Lierde E, Van den Bussche E. Comparing conscious and unconscious conflict adaptation. PLoS One. 2013;8(2):e55976. doi: 10.1371/journal.pone.0055976. Epub 2013 Feb 6.
PubMed 23405242Gantman AP, Adriaanse MA, Gollwitzer PM, Oettingen G. Why did I do that? Explaining actions activated outside of awareness. Psychon Bull Rev. 2017 Oct;24(5):1563-1572. doi: 10.3758/s13423-017-1260-5.
PubMed 28315169Williams LE, Bargh JA, Nocera CC, Gray JR. The unconscious regulation of emotion: nonconscious reappraisal goals modulate emotional reactivity. Emotion. 2009 Dec;9(6):847-54. doi: 10.1037/a0017745.
PubMed 20001127Bargh JA, Gollwitzer PM, Lee-Chai A, Barndollar K, Trotschel R. The automated will: nonconscious activation and pursuit of behavioral goals. J Pers Soc Psychol. 2001 Dec;81(6):1014-27.
PubMed 11761304Bargh JA, Morsella E. The Unconscious Mind. Perspect Psychol Sci. 2008 Jan;3(1):73-9. doi: 10.1111/j.1745-6916.2008.00064.x.
PubMed 18584056
Study at a glance
From the registry record, last updated by the sponsor on 7 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- H22 - Unconscious Mind Training and Memory Encoding
- ClinicalTrials.gov ID
- NCT07597603
- Acronym / sponsor ID
- H22
- Conditions
- Memory Encoding, Memory, Behavior Change Interventions, Habits
- Keywords
- Behavior, Cognitive ability, Unconscious mind
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Dream Video LLCUniversity, hospital or other
- Collaborators
- Dream Holdings Research
- Study start
- Jul 2027 (estimated)
- Primary completion
- Jan 2028 (estimated)
- Study completion
- Jan 2028 (estimated)
- First posted
- 19 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
H22 - Unconscious Mind Training and Memory Encoding
Phase 2.1 in progress.
The core problem this clinical trial, H22, seeks to address is the pervasive challenge of modifying deeply ingrained, often unconscious, unwanted behaviors within the general population. Many individuals struggle with habits or actions that negatively impact quality of life, productivity, or well-being, yet conventional methods often fall short due to the unconscious nature of these behaviors.
Specifically, the trial aims to investigate the efficacy of H22, a novel intervention designed to engage and train the unconscious mind, in mitigating these unwanted behaviors. The central hypothesis guiding this research is that H22 training will empower volunteers to significantly reduce the frequency and intensity of identified unwanted behaviors.
Phase 1 Results:
The trial took place in Shagamu, Nigeria, between July 25, 2026, and August 7, 2026. The study monitored 20 participants over a 14-day intervention period, evaluating their baseline assessment scores, end-of-week progress across Weeks 1 and 2, and their decisions regarding whether to continue integrating Study H22 into daily life.
All 20 enrolled participants completed the full 14 days, yielding a 100% study retention rate. Participant scores improved significantly over the 14 days, increasing from a baseline average of 14.37 to 63.00 at Week 1, and reaching 99.40 by Week 2. At the conclusion of the trial, 85% of participants (17 of 20) chose to continue Study H22 in daily life.
Detailed description
This investigation will rigorously evaluate: Does H22 demonstrably lower the number of unwanted behaviors reported by participants over the trial period, indicating a tangible and measurable impact?
Timeline for Observable Results: What is the typical duration required to observe statistically significant results and behavioral changes when utilizing the H22 methodology, providing insights into its practical application and patient expectations?
To achieve these objectives, participants will engage in a structured and consistent protocol:
Daily H22 Engagement. Each volunteer will commit to performing the H22 training exercises daily for a continuous period of two weeks. This consistent engagement is crucial for assessing the cumulative impact of the intervention on unconscious conditioning.
Mid-Trial Unconscious Mind Survey: After the first week of the trial, participants will complete a specialized survey. This survey is designed to gather qualitative and quantitative data regarding perception of changes in participants unconscious thought patterns, behavioral triggers, and overall mental state as a result of H22.
Behavioral Monitoring Diary. Participants will maintain a daily diary to meticulously record the number of instances participants successfully remembered not to engage in their specified unwanted behavior. This self-reporting mechanism will provide critical empirical data to track progress and validate the effectiveness of H22 in promoting conscious control over previously unconscious actions.
Through this comprehensive approach, this study endeavors to determine if H22 offers a viable, innovative solution for behavioral modification by targeting the unconscious mind, thereby addressing a significant unmet need in personal development and therapeutic interventions.
The design of the intervention is centered around simplicity and consistency: a once-a-day engagement. This frequency is strategically chosen to:
Minimize Barriers to Entry: A short, daily commitment is less daunting than lengthy, infrequent sessions, increasing user adherence.
Promote Habit Formation: Regular, brief interaction facilitates the establishment of a sustainable routine, crucial for long-term results.
Optimize Efficacy: Consistent, focused engagement. The interventions provided by the Investigator are primarily behavioral. Investigators recognize that sustained improvement with the unconscious mind is more than just instruction; it demands a change in daily habits and a commitment to ongoing self-care.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| H22 #1 | Experimental | Behavioral: Intervention H22H22 interventions are administered once daily over a period of fourteen days. |
Who may qualify
- Ages
- 10 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Can read and write
- Willing and able to follow the requirements of the protocol
Key exclusion criteria (1 listed)
- Medical instability, restlessness, or other factors that would compromise data acquisition
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intervention H22Unconscious Mind Training. | Behavioural | H22 #1 |
Primary outcome
Proportion of volunteers achieving measurable improvements with unconscious training following a two-week treatment protocol.
Time frame: From enrollment to the end of treatment at 2 weeks
Compare the number of participants experiencing treatment-related adverse events versus those with positive treatment outcomes.
Time frame: From enrollment to the end of treatment at 2 weeks.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Oct 2026.
- Background: PubMed 30740277Meng F, Li A, You Y, Xie C. Motor expertise modulates unconscious rather than conscious executive control. PeerJ. 2019 Feb 5;7:e6387. doi: 10.7717/peerj.6387. eCollection 2019.
- Background: PubMed 23405242Desender K, Van Lierde E, Van den Bussche E. Comparing conscious and unconscious conflict adaptation. PLoS One. 2013;8(2):e55976. doi: 10.1371/journal.pone.0055976. Epub 2013 Feb 6.
- Background: PubMed 28315169Gantman AP, Adriaanse MA, Gollwitzer PM, Oettingen G. Why did I do that? Explaining actions activated outside of awareness. Psychon Bull Rev. 2017 Oct;24(5):1563-1572. doi: 10.3758/s13423-017-1260-5.
- Background: PubMed 20001127Williams LE, Bargh JA, Nocera CC, Gray JR. The unconscious regulation of emotion: nonconscious reappraisal goals modulate emotional reactivity. Emotion. 2009 Dec;9(6):847-54. doi: 10.1037/a0017745.
- Background: PubMed 11761304Bargh JA, Gollwitzer PM, Lee-Chai A, Barndollar K, Trotschel R. The automated will: nonconscious activation and pursuit of behavioral goals. J Pers Soc Psychol. 2001 Dec;81(6):1014-27.
- Background: PubMed 18584056Bargh JA, Morsella E. The Unconscious Mind. Perspect Psychol Sci. 2008 Jan;3(1):73-9. doi: 10.1111/j.1745-6916.2008.00064.x.
- Individual participant dataSharing planned: No
Related trials for Memory Encoding
Active, not recruiting
Impact of Insomnia Treatment on Brain Responses During Resting-state and Cognitive Tasks
Chronic Insomnia
Recruiting
Validation of a Remediation Method for Memory Impairments Through Motor Encoding in Patients With Alzheimer's Disease
Alzheimer s Disease, Healhty
Not yet recruitingEarly Phase 1
Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation
Epilepsy, Essential Tremor
Active, not recruiting
Basic Experimental Study of Hippocampal Memory Functions
Memory
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Matthew Quitto II study director
Dream Video LLC
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intervention H22 in people with Memory Encoding and Memory, run by Dream Video LLC at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Matthew Quitto II (9173422895, dream@dreamholdingsllc.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of volunteers achieving measurable improvements with unconscious training following a two-week treatment protocol. (time frame: From enrollment to the end of treatment at 2 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07597603, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.